elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Ovarian cancer
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Ovarian cancer
RIS
0.006
(Research Intensity Score)
Papers
707
Top papers
Ovarian Cancer
2025 · 226 citations
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
2023 · 457 citations
Clinical and translational advances in ovarian cancer therapy
2023 · 375 citations
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 · 378 citations
Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions
2025 · 92 citations
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
2019 · 2289 citations
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance
2023 · 225 citations
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
2025 · 84 citations
Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation
2025 · 68 citations
Newest papers
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
2026 · 16 citations
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome
2026 · 9 citations
Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial
2026 · 7 citations
Chemoresistance in ovarian cancer (I)
2026 · 8 citations
Ovarian Cancer
2025 · 226 citations
Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions
2025 · 92 citations
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
2025 · 84 citations
Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation
2025 · 68 citations
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
2025 · 53 citations
Browse all papers →
Ovarian cancer's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Ovarian cancer's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link